- Services & Solutions
- Clients & Partners
Society for Immunotherapy of Cancer (SITC) 2019
November 6, 2019 to November 10, 2019
National Harbor, MD │ Gaylord National Hotel & Convention Center
SRI researchers will present preclinical data demonstrating the potential of our novel Targeted Antigen Loaded Liposomes (TALL) technology to help treat lung and breast cancers. TALL leverages the immune system to kill cancer by tricking it into thinking cancer cells are infected with a serious virus.
Poster #P124 A Novel Cell-Mediated Immunotherapy for Treatment of Lung and Breast Cancer
Date/Time: Saturday, November 9, 7:00 a.m.-8:30 p.m.
Prince George's Exhibition Halls AB